| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/26/2005 | CN1569147A Tripterygium hypoglaucum contained transdermal plaster and its preparation |
| 01/26/2005 | CN1569141A Externally applied |
| 01/26/2005 | CN1569120A Effective portion extraction of dogwood and its preparation method and usage |
| 01/26/2005 | CN1569088A 'Heiguteng' exract, its pharmaceutical composition and its use |
| 01/26/2005 | CN1569078A Medicine for treating urinary system disease and preparation method |
| 01/26/2005 | CN1569019A Application of arctium fruit glycoside in the preparing process of nephritis treating medicine |
| 01/26/2005 | CN1569010A Etimicin sulfate preparation and its preparing method |
| 01/26/2005 | CN1568976A Application of bendazac lysine in the preparing process of medicine for preventing and treating diabetic nephropathy |
| 01/26/2005 | CN1568959A Prostate hyperplasia preventing prescriptions |
| 01/26/2005 | CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/26/2005 | CN1186097C Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor |
| 01/26/2005 | CN1186053C Medicine for treating kidney disease and its preparation method |
| 01/26/2005 | CN1186048C Health tea for treating gynecopathy, urinary system and upper respiratory tract disease |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846499 Medical effect of jojoba oil |
| 01/20/2005 | WO2005005397A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | WO2005004989A2 Film comprising therapeutic agents |
| 01/20/2005 | WO2005004914A1 MEDICINAL COMPOSITION CONTAINING NF-κB DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 01/20/2005 | WO2005004913A1 Pharmaceutical composition containing decoy and method of using the same |
| 01/20/2005 | WO2005004889A1 Herbal compositions for the treatment and prevention of prostate disorders |
| 01/20/2005 | WO2005004869A1 Use of cgrp antagonists in treatment and prevention of hot flushes in prostate cancer patients |
| 01/20/2005 | WO2005004639A1 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 01/20/2005 | WO2004111046A3 Thiazoles as inhibitors of the alk- 5 receptor |
| 01/20/2005 | WO2004038408A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014841 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 01/20/2005 | US20050014831 Cancer, hypertension, obesity; diseases mediated by alteration of membrane structure and regulation of G-proteins or receptors |
| 01/20/2005 | US20050014799 In mixture with enzyme inhibitors and other active materials |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014741 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/20/2005 | US20050014699 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 01/20/2005 | US20050014686 Somatostatin analogues |
| 01/20/2005 | US20050014675 Therapy for vascular system disease; using growth hormonr secretion promoter compound ; artheriosclerosis; cardiovascular disorders; anticholesterol agents |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014187 Novel polypeptide hormone phosphatonin |
| 01/20/2005 | US20050013821 Mint extract and related pharmaceutical compositions |
| 01/20/2005 | CA2531629A1 Medicinal composition containing nf-.kappa.b decoy for treating and preventing respiratory diseases and method of using the same |
| 01/20/2005 | CA2531417A1 Herbal compositions for the treatment and prevention of prostate disorders |
| 01/20/2005 | CA2531407A1 Use of cgrp antagonists in treatment and prevention of hot flushes in prostate cancer patients |
| 01/20/2005 | CA2530843A1 Film comprising therapeutic agents |
| 01/20/2005 | CA2530450A1 5-substituted quinazolinone derivatives |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1497288A1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament |
| 01/19/2005 | EP1497284A2 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 01/19/2005 | EP1496940A2 Methods of treating diabetes using pde 11a inhibitors |
| 01/19/2005 | EP1496929A1 Use of c5a receptor antagonist in the treatment of fibrosis |
| 01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496890A1 Substituted beta-aminoalcohols used as medicaments |
| 01/19/2005 | EP1496883A1 Method for treating ileus with an alpha-ketoalkanoic acid, ester or amide |
| 01/19/2005 | EP1496882A1 Tolterodine salts |
| 01/19/2005 | EP1496881A2 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 01/19/2005 | EP1496877A2 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/19/2005 | EP1337254B1 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence |
| 01/19/2005 | EP1230244B1 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568321A Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/19/2005 | CN1568194A Modulation of smooth muscle cell proliferation |
| 01/19/2005 | CN1568180A Pharmaceutical formulations for the controlled release of 4-amino-6, 7-dimethoxy-2-(5-methanesulfonamido-1, 2, 3, 4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)-quinazoline |
| 01/19/2005 | CN1566108A Red clover total flavone high content extract, preparation and application in pharmaceutical combination thereof |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1565608A Botanical medicine for treating urinary system calculi, its compositions and preparing method |
| 01/19/2005 | CN1565603A Preparing method of several Chinese herbal prescription |
| 01/19/2005 | CN1565594A Chinese patent drug for treating kidney disease and its preparing process |
| 01/19/2005 | CN1565530A Medicine for treating urinary incontinence and its preparing process |
| 01/19/2005 | CN1565502A Novel formulation of 'GuiFu Dihuang' and its preparing method |
| 01/19/2005 | CN1565485A Brain tonifying and kidney invigorating medicinal capsule |
| 01/19/2005 | CN1565484A Detoxicating and kidney defending clyster powder |
| 01/19/2005 | CN1565453A 6-amino-ª‡(R)-hydroxyl-9H-purin-9-ethyl butyrate immunological suppression effect |
| 01/19/2005 | CN1185227C Novel compounds |
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1184991C Chinese traditional medicine preparation for treating glomerulonephritis |
| 01/19/2005 | CN1184974C Traditional Chinese medicine compositions for treating prostatitis, impotence and ejaculation praecox |
| 01/19/2005 | CN1184964C Use of carbonylamino derivatives against CNS disorders |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/18/2005 | US6844345 Piperazine derivatives |
| 01/18/2005 | US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 01/18/2005 | US6844336 4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity |
| 01/18/2005 | US6844320 Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
| 01/18/2005 | US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC |
| 01/18/2005 | US6843980 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/13/2005 | WO2005002614A1 Methods and compositions for treating disorders of the extracellular matrix |
| 01/13/2005 | WO2005002599A1 Buffered compositions for dialysis |
| 01/13/2005 | WO2004089379A3 Pharmaceutical combination containing tamsulosin and a non-steroidal anti-inflammatory drug |
| 01/13/2005 | WO2004082567A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 01/13/2005 | WO2004042077A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
| 01/13/2005 | WO2003089569A3 Use of il-19, il-22 and il-24 to treat hematopoietic disorders |